The increase in head and neck cancer cases is the primary driver of the head and neck cancer market. A few other factors influencing the growth of the global head and neck cancer market include the ageing population, significant funding for oncology research, unmet medical needs, growing market competition, improved regulatory framework, the ageing population, and rising government support. Despite these factors, the head and neck cancer industry causes concern.
In low- and middle-income countries, the high cost of therapy may impede market expansion, the shortcomings of current treatments, the lack of healthcare coverage, and the insufficient healthcare systems. It is anticipated that as scientific and technological advancements in R&D and manufacturing processes increase, the efficiency of medication development will also rise.
Read More:
https://knackersblogger.blogspot.com/2023/01/antibody-drug-conjugates-creates-major.html
